Legit.ng on MSN

How to apply for FG's TVET phase two programme and earn a monthly stipend

The Federal Government launches phase two of the TVET programme, enhancing skills for young Nigerians, boosting employability ...

LOCAL NOTES: Recovery Demystified offers new support and community events in July

This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...
Center on Budget and Policy Priorities

House Reconciliation Bill Proposes Deepest SNAP Cut in History, Would Take Food Assistance Away From Millions of Low-Income Families

[6] All States Would Face Significant Increased Costs, Many Would Owe Far More Since SNAP’s start in its current form nearly 50 years ago, the federal government has fully funded the cost of SNAP food ...

Nevada launches new online application for Pre-K programs

A new common application for Nevada Ready! pre-K programs is now available, giving families a single pathway to apply to more than 90 participating pre-K programs across the state. The application was ...
Hoodline

Sacramento Rent Hike Limit Jumps, Tenants Face 8.6 Percent Hit

Starting July 1, renters in Sacramento who live in units covered by the city’s Tenant Protection Program are dealing with a new number: the maximum annual rent increase has been set at 8.6%. For those ...
Communications of the ACM

The LLVM Compiler Infrastructure

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...
JD Supra

Registered Offering Reform The SEC’s proposed changes to Securities Act registration form eligibility, pre- and post-offering communications and other matters

The Securities and Exchange Commission (SEC) is proposing to make significant changes to the eligibility of issuers to utilize Securities ...
TMCnet

LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations

LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

Recently closed $50 million underwritten offering reinforces strong institutional investor conviction and bolsters balance sheet for execution of second Phase 3 HLP003 trial1- 2,3, EMBRACE, for potent ...